Skip to main content
Equibles

Kiza Ding

Analyst

Rothschild & Co.

Equibles does not estimate personal net worth.

About Kiza Ding

Kiza Ding is recorded as Analyst at Rothschild & Co.. Kiza Ding has spoken on 1 earnings call across 1 company, most recently for Genmab A/S on February 17, 2026. The companies whose calls Kiza Ding spoke on are classified in the Healthcare sector.

Kiza Ding on recent calls

“So I noticed that the PETO sentiment is at phase two stage for combining temporal supermap in first-line non-small cell lung cancer. Just wanted to clarify, is this a new trial that was started in Q4 2025?”
Analyst — Rothschild & Co., Genmab A/S Q4 FY2025 Earnings Call ·

Affiliation history

  • Rothschild & Co.

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity